# Praneeth Kudaravalli

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/praneeth-kudaravalli/

## Facts

| Field | Value |
| --- | --- |
| Citations | 265 |
| Field | Inflammatory Bowel Disease |
| h-index | 9 |
| i10-index | 8 |
| Last Known Institution | Porter Adventist Hospital |
| OpenAlex ID | https://openalex.org/A5020168900 |
| ORCID iD | 0000-0001-8242-8729 |
| Works | 51 |

## Researcher papers

- [Efficacy, safety and pharmacokinetics of biosimilars of anti-tumor necrosis factor-α agents in rheumatic diseases; A systematic review and meta-analysis](https://scholariq.org/papers/efficacy-safety-and-pharmacokinetics-of-biosimilars-of-anti-tumor-necrosis/)
- [Endoscopic submucosal dissection vs. endoscopic mucosal resection for early Barrett's neoplasia in the West: a retrospective study](https://scholariq.org/papers/endoscopic-submucosal-dissection-vs-endoscopic-mucosal-resection-for-early/)
- [Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease](https://scholariq.org/papers/ustekinumab-dose-escalation-improves-clinical-responses-in-refractory-crohn-s/)
- [Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative Colitis](https://scholariq.org/papers/vedolizumab-dose-escalation-improves-therapeutic-response-in-a-subset-of/)
- [Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma](https://scholariq.org/papers/using-nomogram-of-the-barcelona-clinic-liver-cancer-system-for-treatment/)
- [Campylobacter infection and the link with Irritable Bowel Syndrome:<i>on the pathway towards a causal association</i>](https://scholariq.org/papers/campylobacter-infection-and-the-link-with-irritable-bowel-syndrome-i-on-the/)
- [Superior Mesenteric Artery Syndrome](https://scholariq.org/papers/superior-mesenteric-artery-syndrome/)
- [Expanding beyond endoscopy: A review of non-invasive modalities in Barrett’s esophagus screening and surveillance](https://scholariq.org/papers/expanding-beyond-endoscopy-a-review-of-non-invasive-modalities-in-barrett-s/)
- [Chronic Pancreatitis Patients Who Leave Against Medical Advice: Prevalence, Trend, and Predictors](https://scholariq.org/papers/chronic-pancreatitis-patients-who-leave-against-medical-advice-prevalence-trend/)
- [1487 Vedolizumab-Induced Remission of Refractory Microscopic Colitis: A Single Institution Case Series](https://scholariq.org/papers/1487-vedolizumab-induced-remission-of-refractory-microscopic-colitis-a-single/)
- [Comprehensive analysis of adverse drug reactions associated with teduglutide: post-marketing insights and safety implications](https://scholariq.org/papers/comprehensive-analysis-of-adverse-drug-reactions-associated-with-teduglutide/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Esophageal and GI Pathology](https://scholariq.org/topics/esophageal-and-gi-pathology/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)

## Researcher university

- [Porter Adventist Hospital](https://scholariq.org/institutions/porter-adventist-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.